Use of Capital Increase Proceeds for Overseas Bases, Research and Development, and Production Facilities
First written in FY2016. 3 of 4 entries say "Restated". Latest entry: FY2019.
12 other companies' latest entry also says "Restated".
- FY2019RestatedAnnual report
「The funds will be used to establish overseas bases to strengthen our global organisation and structure and for capital investment in R&D facilities.」
The policy of allocating funds to overseas bases and R&D facilities has been maintained. - FY2018RestatedAnnual report
「The funds will be used to establish overseas bases to strengthen our global organisation and structure, acquire machinery and equipment for R&D, and invest in information infrastructure and related facilities for sales and production management.」
The policy of allocating funds to overseas bases, machinery and equipment for R&D, and information infrastructure for sales and production management has been maintained. - FY2017RestatedAnnual report
「The funds will be used to establish overseas bases to strengthen our global organisation and structure, acquire machinery and equipment for R&D, and invest in information infrastructure and related facilities for sales and production management.」
The company reiterates its policy of allocating funds to overseas bases, machinery for R&D and information infrastructure, among other uses. - FY2016First statedAnnual report
「The proceeds from the issuance of new shares are planned to be used for establishing overseas bases, acquiring machinery and equipment for R&D aimed at developing new markets, expanding factory facilities to increase production capacity, and capital investment in information infrastructure and related areas.」
The planned uses of the capital increase proceeds include overseas bases, machinery for R&D, production equipment and information infrastructure.